-
Bora Adds Four Business Development Directors
contractpharma
July 24, 2020
Bora Pharmaceuticals, a full-service contract development and manufacturing organization (CDMO) which specializes in immediate and modified release tablets and capsules, along with serialized packaging, has appointed four business development directors..
-
Polpharma Fully Integrates Bioceros
contractpharma
July 16, 2020
In 2016, Polpharma Biologics acquired Dutch based Bioceros and their proprietary cell line development platform CHOBC, as well as their discovery, process development and analytical capabilities.
-
Vetter Further Expands its Development Service with New Site in Austria
b3cnewswire
July 09, 2020
With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions.
-
Rentschler Biopharma and Vetter Enter Partnership
contractpharma
July 07, 2020
Two CDMOs team up with joint goal to simplify processes and optimize time-to-market.
-
GRAM Opens Large-Scale Injectable Fill/Finish Facility
contractpharma
July 06, 2020
Grand River Aseptic Manufacturing (GRAM), an agile and modern parenteral contract development and manufacturing organization (CDMO), completed its major $60 million expansion project and recently took occupancy.
-
Symbiosis Secures $1.25M of Financing from Allied Irish Bank
contractpharma
July 06, 2020
The fast growing Scottish CDMO will use the funds to support its 2020 growth strategy.
-
Emergent BioSolutions Enters Viral Vector and Gene Therapy Arena
contractpharma
June 19, 2020
Invests $75mn in Canton site, advanced therapy CDMO drug substance manufacturing services expected to be available beginning in 2023.
-
Fujifilm commits $928m to expand biologics facility in Denmark
pharmaceutical-technology
June 11, 2020
Fujifilm expects the capital investment to double the Denmark site's existing drug substance manufacturing capacity.
-
FUJIFILM Investing $928M in Denmark CDMO Site
contractpharma
June 10, 2020
Will double the site's current drug substance manufacturing capacity and will expand capabilities to include fill/finish.
-
Alcami Names New CEO
contractpharma
June 05, 2020
30-year pharma vet Walter J. Kaczmarek III takes the helm at the CDMO.